HIV derived glycoprotein 120: Potential ethiological agent for AIDS associated dementia;La glicoproteína 120 del VIH: Potential agente etiológio de la demencia asociada al SIDA

Revista de Investigacion Clinica

Volumn 54, Issue 5, 2002, Pages 437-452

  Galicia, Oscar ^a,b   Sánchez Alvarez, Manuel ^a,c   Méndez Díaz, Mónica ^a   Navarro, Luz ^a   Prospero García, Óscar ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

AIDS; Chemokines; Glutamate; HIVgp 120; Memory; Sleep; Vasoactive intestinal peptide

Indexed keywords

CALCIUM; GLUTAMIC ACID; GLYCOPROTEIN GP 120; INOSITOL PHOSPHATE; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BRAIN INJURY; CALCIUM CELL LEVEL; CALCIUM CONDUCTANCE; CALCIUM TRANSPORT; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOPLASM; DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MEMORY DISORDER; MICROGLIA; MOTOR CONTROL; MOTOR DYSFUNCTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; SENSORY DYSFUNCTION; SIGNAL TRANSDUCTION; SMOOTH ENDOPLASMIC RETICULUM;

AIDS DEMENTIA COMPLEX; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTI-HIV AGENTS; CALCIUM SIGNALING; CELL DEATH; CHEMOKINES; DISEASE MODELS, ANIMAL; DRUG DESIGN; EVENT-RELATED POTENTIALS, P300; GLUTAMIC ACID; HAPLORHINI; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MAP KINASE SIGNALING SYSTEM; MICROGLIA; PRION DISEASES; RECEPTORS, CHEMOKINE; RECEPTORS, VIRUS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRUS REPLICATION;

EID: 0036766879     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Grant I, Heaton R, Atkinson J. Neurocognitive disorders in HIV-1 infection. In: M. Oldstone, and L. Vitkovic (eds). Neurocognitive disorders in HIV-1 infection. Berlin: Springer-Verlag; 1995, p. 11-32.
2. Piot P, Plummer F, Mhalu F, Lamboray JL, Chin J, Mann J. AIDS: An international perspective. Science 1988; 239; 573-9.
3. ONUSIDA, and OMS, Latest HIV/AIDS Statistics, http://www.unaids.org/, 2000.
4. Frankel A, Young J. HIV-1: Fifteen proteins and an RNA. Annu Rev Biochem 1998; 67: 1-25.
5. Kuby J. Immunology. New York Library of Congress, 1998.
6. Poignard P, Ollmann E, Parren P, Burton D. Gp120: Biological aspects of structural features. Annu Rev Immunol 2001; 19: 253-74.
7. Turner B, Summers M. Structural biology of HIV. J Mol Biol 1999; 285(1): 1-32.
8. Ashorn P, Berger E, Moss B. Human immunodeficiency virus envelope glycoprotein CD4 mediated fusion of nonprimate cells with human cells. J Virol 1990; 64(5): 2149-56.
9. Berger E, Murphy P, Farber J. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism and disease. Ann Rev Immunol 1999; 17: 657-700.
10. Baggiolini M, Dewald B, Moser B. Human chemokines: An update. Annu Rev Immunol 1997; 15: 675-705.
11. Murphy P, Baggiolini M, Charo I, Hebert C, Horuk R, Matsushima K, Miller L, Power JOC. International Union of Pharmacology. XXII nomenclature for chemokine receptors. Pharmacological Reviews 2000; 52(1): 145-68.
12. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18: 217-42.
13. Locati M, Murphy P. Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS. Annu Rev Med 1999; 50: 425-40.
14. Ward S, Westwick J. Chemokines: Understanding their role in T-lymphocyte biology. Biochem J 1998; 333: 457-70.
15. Gabuzda D, He J, Ohagen A, Vallat AV. Chemokine receptors in HIV-1 infection of the central nervous system. Immunology 1998; 10: 203-13.
16. He J, Chen Y, Farzan M, Choe H, Ohagen A. CCR3 and CCR5 are coreceptors for HIV-1 infection of microglia. Nature 1997; 385: 645-9.
17. Donaldson Y, Bell J, Holmes E, Hughes E, Brown H, Simmonds P, In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the v3 loop. Journal of Virology 1994; 68(9): 5991-6005.
18. Power C, McArthur J, Nath A, Wehrly K, Mayne M, Nishio J, Langelier T, Johnson R, Chesebro B. Neuronal death induced by brain derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patients. Journal of Virology 1998; 72(11): 9045-53.
19. Connor R, Notermans D, Mohri H, Cao Y, Ho D. Biological cloning of functionally diverse quasispecies of HIV-1. AIDS Res Hum Retroviruses 1993; 9(6): 541-6.
20. Connor R, Sheridan K, Ceradini D, Choe S, Landau N. Change in coreceptor use correlates with disease progresion in HIV-1 infected individuals. J Exp Med 1997; 185(4): 621-8.
21. Bates ME, Green V, Bertics P. ERK1 and ERK2 activation by chemotactic factors in human eosinophils is interleukin 5 dependent and contributes to leukotriene C4 biosyntehesis. J Biol Chem 2000; 275(15): 10968-75.
22. Baggiolini M. Reflections on chemokines. Immunol Rev 2000; 177: 5-7.
23. Ganju R, Brubaker S, Chernock R, Avraham S, Groopman J. Beta chemokine receptor CCR5 signals through SHP1, SHP2 and Syk. J Biol Chem 2000; 275(23): 17263-8.
24. Ganju R, Brubaker S, Meyer J, Dutt P, Yang Y, Qin S, Newman W, Groopman J. The alfa chemokine stromal cell-derived factor 1 alfa, binds to the transmembrane G protein coupled CXCr4 receptor and activates multiple signal transduction pathways. J Biol Chem 1999; 273(36): 23169-75.
25. Lannuzel A, Barnier JV, Hery C, Tan HV, Guibert B, Gray F, Vincent JD, Tardieu M. Human immunodeficiency virus type 1 and its coat protein gp120 induce apoptosis and activate JNK and ERK mitogen activated protein kinases in human neurons. American Neurological Association 1997; 42(6): 847-56.
26. Price R, Perry R. HIV, AIDS and the brain. New York: Raven Press; 1996.
27. Lipton S. Neuronal injury associated with HIV-1: Approaches to treatment. Annu Rev Pharmacol Toxicol 1998; 38: 159-77.
28. Ostrosky-Solís F, Demencias tratables y no tratables. In: F Ostrosky A, Ardila, R Chayo (eds). Demencias tratables y no tratables. México: Planeta; 1996, p. 203-19.
29. Price R, Brew B, Sidtis J, Rosenblum M, Scheck A, Cleary P. The brain and AIDS: Central nervous system HIV-1 infection and AIDS demential complex. Science 1988; 239: 586-92.
30. Brew B, Resenblum M, Cronin K, Price R. AIDS dementia complex an HIV-1 brain infection: Clinical virological correlations. Ann Neurol 1995; 38(4): 563-70.
31. Levy J. HIV and the pathogenesis of AIDS. Washington D.C: ASM Press; 1994.
32. Rottenberg D, Sidtis J, Strther K, Anderson J, Nelson M, Price R. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 1996; 37: 1133-41.
33. Wiley CA. Quantitative neuropathologic assessment of HIV-encephalitis. In: M. B. A. Oldstone, and L. Vitkovic (eds). Quantitative neuropathologic assessment of HIV-encephalitis. New York: Springer; 1995.
34. Bennett B, Rusyniak D, Hollingsworth C. HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. Brain Research 1995; 705: 168-76.
35. Petito C, Roberts B, Cantando J, Rabinstein A, Duncan R. Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. J Neuropathol Exp Neurol 2001; 60(4): 377-85.
36. An S, Giometto B, Scaravilli T, Tavolato B, Gray F, Scarvilli F. Programmed cell death in brains of HIV-1 positive AIDS and pre AIDS patients. Acta Neuropathol 1996; 91(2): 169-73.
37. Kaul M, Garden G, Lipton S. Pathways to neuronal injury and apoptosis in HIV- associated dementia. Nature 2001; 410 (6831): 988-94.
38. Arendt G, Hefter H, Neuen-Jacob E, Wist S, Kuhlmann H, Strohmeyer G, Freund H. Electrophysiological motor testing MRI findings and clinical course in AIDS patients with dementia. J Neurol 1993; 240(7): 439-45.
39. Kure K, Lyman W, Weidenheim K, Dickson D. Cellular localization of an HIV-1 antigen in subacute AIDS encephalitis using an improved double labeling immumohistochemical method. Am J Pathol 1990; 136(5): 1085-92.
40. Shaw G, Harper, M, Hahn B, Epstein L, Gajdusek D, Price R, Navia B, Petito C, O'Hara C, Groopman J, Cho E, Oleske J, Wong-Staal M, Gallo R. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 1985; 227: 177-82.
41. Gabuzda D, Ho D, Monte Sdl, Hirsch M, Rota T, Sobel R. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol 1986; 20(3): 289-95.
42. Pumarola-Sune T, Navia B, Cordon-Cardo C, Cho E, Price R. HIV antigen in the brains with the AIDS dementia complex. Ann Neurol 1987; 21(5): 490-6.
43. Wiley C, Schrier R, Richmann D, Nelson J, Lambert P, Oldstone M. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci 1986; 83: 7089-93.
44. Levy J, Shimabukuro J, Hollander H, Mills J, Kaminsky L. Isolation of AIDS associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 1985; 2(8455): 596-8.
45. Haas DW, Clough LA, Johnson BW, Harris VL, Spearman P, Wilkinson GR. et al. Evidence of a source of HIV-1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma. AIDS Res Hum Retrovirus 2000; 16(15): 1401-502.
46. Epstein J, Frederick W, Rook A, Jackson L, Mainschewitz J, Mayner R. et al. Selective defects in cytomegalovirus and mitogen induce lymphocyte proliferation an interferon release in patients with acquired immunodeficiency syndrome. J Infect Dis 1985; 152(4): 727-33.
47. Brenneman D, Westbrook G, Fitzgerald S, Ennist D, Elkins K, Ruff M, Pert C. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988; 335: 639-42.
48. Toggas S, Masliah E, Rockenstein E, Rall G, Mucke CAL. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 1994; 367: 188-93.
49. Lipton S. Models of neural injury in AIDS: Another role for the NMDA receptor? TINS 1992; 15(3): 75-9.
50. Wu P, Price P, Du B, Hatch W, Terwilliger E. Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. Neuroreport 1996; 7(5): 1045-9.
51. Meucci, O, Miller R. gp120-induced nuerotoxicity in hipocampal pyramidal neuron cultures: Protective action of TGF-beta1. The Journal of Neuroscience 1996; 16(13): 4080-8.
52. Lo TM, Fallert C, Piser T, Thayer S. HIV-1 envelope protein evokes intracellular calcium oscillations in rat hippocampal neurons. Brain Research 1992; 594: 189-96.
53. Benos D, Hahn B, Bubien J, Ghosh S, Mashburn N, Chakin M, Shaw G, Benveniste E. Envelope glycoprotein gp120 of human immunodeficiency virus type 1 alters ion transport in astrocytes: Implications for AIDS dementia complex. Proc Natl Acad Sci USA 1994; 91: 494-8.
54. Giulian D, Vaca K, Noonan C. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250: 1593-6.
55. Giulian D, Wendt E, Vaca K, Noonan C. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci 1993; 90: 2769-73.
56. Berman N, Marcario J, Yong C, Raghavan R, Raymond L, Joang S et al. Microglial activation and neurological symptoms in the SIV model Neuro AIDS: Association of MHC-II and MMp9 expression with behavioral deficits and evoked potentials. Neurobiol Dis 1999; 6(6): 486-98.
57. Phillips TR, Prospero-García O, Puaoi DL, Lerner DL, Fox HS, Olmsted RA et al. Neurological abnormalities associated with feline immunodeficiency virus infection. Journal of General Virology 1994; 75: 979-87.
58. Prospero-García O, Herold N, Phillips TR, Elder JH, Bloom F, Henriksen SJ. Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Nat Acad Sci Usa 1994; 91; 12947-51.
59. Prospero-García O, Reséndiz SH, Casalman SC, Sánchez-Alavez M, Díaz-Ruiz O, Navarro L. Feline immunodeficiency virus envelope protein (FIV gp120) causes electrophysiological alterations in rats. Brain Research 1999; 836: 203-9.
60. Sánchez-Alavéz M, Criado J, Gómez-Chavarín M, Jiménez-Anguiano A, Navarro L, Díaz-Ruiz O, Galicia O. et al. HIV and FIV derived gp120 alter spatial memory, LTP and sleep in rats. Neurobiol Dis 2000; 7(4): 384-94.
61. Ollo C, Johonson R, Grafman J. Signs of cognitive change in HIV disease: An event related brain potential study. Neurology 1991; 41: 209-15.
62. Galicia O, Brailowsky S. Atención: La compuerta de la conciencia. Salud Mental 1999; 22(3): 48-59.
63. Galicia O, Sánchez-Alavéz M, Díaz-Ruiz O, Sánchez-Narváez F, Elder J, Navarro L, Prospero-García O. HIV-derived protein gp120 suppresses P3 potential in rats: Potential implications in HIV-associated dementia. Neuroreport 2000; 11: 6: 1351-5.
64. Fein G, Biggins C, Mackay S. Delayed latency of the event related brain potential P3a component in HIV disease. Arch Neurol 1995; 52: 1109-18.
65. Goodin D, Aminoff M, Chernof D, Hollander H. Long latency event related potentials in patients infected with human immunodeficiency virus. Ann Neurol 1990; 27: 414-19.
66. Frank Y, Pahwa S. Serial brainstem auditory evoked responses in infants and children with AIDS. Clin Electroencephalogr 1993; 24(4): 160-5.
67. Sánchez-Alavéz M, Navarro L, Díaz-Ruiz O, Castillo OG, Sánchez-Narváez F, Murillo-Rodríguez E, et al. Aspectos Moleculares de la dementia asociada al SIDA. Salud Mental 1999; 22(2): 49-65.
68. Birdsall H, Ozluoglu L, Lew H, Trial J, Brown D, Wofford M, Jerger J, Rossen R. Auditory P300 abnormalities and leukocyte activation in HIV infection. Otolaryngol Head Neck Surg 1994; 110(1): 53-9.
69. Coburn K, Moore N, Katner H, Tucker K, Pritchard W, Duke D. HIV and the brain: Evidence of early involvement and progressive damage. Neuroreport 1992; 3(6): 539-41.
70. Connolly S, Manji H, McAllister R, Fell M, Loveday C, Kirkis C. et al. Long latency event related potentials in asymptomatic human immunodeficiency virus type 1 infection. Ann Neurol 1994; 35: 189-96.